Skip to content

Sustained response to treatment reduces fatigue in hepatitis C patients

Investigational protease inhibitor TMC310911 highly potent in phase 2 study

Sofosbuvir + ribavirin for 24 weeks is highly effective against HCV genotype 4

Early antiretroviral treatment reduces risk of AIDS and HIV-related illness

PCR testing reveals high prevalence of CNS infections among people living with HIV in Zambia with CNS symptoms

Methadone and buprenorphine-naloxone both associated with reduced HIV risk among people who inject drugs

Implementation of a comprehensive harm reduction programme curtailed the HIV epidemic among people who inject drugs in Taiwan

HIV infection increases risk of melanoma

Three-drug AbbVie combination safe and highly effective in treatment of post-transplant hepatitis C recurrence